IRIS Accounts Production v23.3.1.45 14439749 Board of Directors 24.10.22 31.10.23 31.10.23 false true false false true false Ordinary shares 1.00000 Ordinary A shares 1.00000 Ordinary B shares 1.00000 Ordinary C Shares 1.00000 Ordinary D Shares 1.00000 1.00000 1.00000 1.00000 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh144397492022-10-23144397492023-10-31144397492022-10-242023-10-31144397492022-10-2314439749ns10:Originalns15:EnglandWales2022-10-242023-10-3114439749ns14:PoundSterlingns10:Original2022-10-242023-10-3114439749ns10:Originalns10:Director12022-10-242023-10-3114439749ns10:Original2022-10-242023-10-3114439749ns10:Original2023-10-3114439749ns10:Originalns10:PrivateLimitedCompanyLtd2022-10-242023-10-3114439749ns10:Originalns10:SmallEntities2022-10-242023-10-3114439749ns10:Originalns10:AuditExempt-NoAccountantsReport2022-10-242023-10-3114439749ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-10-242023-10-3114439749ns10:SmallCompaniesRegimeForAccountsns10:Original2022-10-242023-10-3114439749ns10:Originalns10:FullAccounts2022-10-242023-10-3114439749ns10:Originalns10:OrdinaryShareClass12022-10-242023-10-3114439749ns10:Originalns10:OrdinaryShareClass22022-10-242023-10-3114439749ns10:OrdinaryShareClass3ns10:Original2022-10-242023-10-3114439749ns10:Originalns10:OrdinaryShareClass42022-10-242023-10-3114439749ns10:Originalns10:OrdinaryShareClass52022-10-242023-10-3114439749ns10:Originalns10:OrdinaryShareClass112022-10-242023-10-31144397492ns10:Originalns10:OrdinaryShareClass22022-10-242023-10-3114439749ns10:OrdinaryShareClass3ns10:Original32022-10-242023-10-3114439749ns10:Original4ns10:OrdinaryShareClass42022-10-242023-10-3114439749ns10:Original5ns10:OrdinaryShareClass52022-10-242023-10-3114439749ns10:Originalns10:Director22022-10-242023-10-3114439749ns10:Originalns10:RegisteredOffice2022-10-242023-10-3114439749ns10:Originalns5:CurrentFinancialInstruments2023-10-3114439749ns5:ShareCapitalns10:Original2023-10-3114439749ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-10-3114439749ns10:Originalns5:FurnitureFittings2022-10-242023-10-3114439749ns10:Originalns5:FurnitureFittings2023-10-3114439749ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-10-3114439749ns10:Originalns10:OrdinaryShareClass12023-10-3114439749ns10:Originalns10:OrdinaryShareClass22023-10-3114439749ns10:OrdinaryShareClass3ns10:Original2023-10-3114439749ns10:Originalns10:OrdinaryShareClass42023-10-3114439749ns10:Originalns10:OrdinaryShareClass52023-10-31
REGISTERED NUMBER: 14439749 (England and Wales)















FINANCIAL STATEMENTS FOR THE PERIOD 24 OCTOBER 2022 TO 31 OCTOBER 2023

FOR

NW Diagnostics Limited

NW Diagnostics Limited (Registered number: 14439749)






CONTENTS OF THE FINANCIAL STATEMENTS
for the period 24 October 2022 to 31 October 2023




Page

Company Information 1

Balance Sheet 2 to 3

Notes to the Financial Statements 4 to 6


NW Diagnostics Limited

COMPANY INFORMATION
for the period 24 October 2022 to 31 October 2023







Directors: Mrs J A Foster
R S Foster





Registered office: Stamford
Aish
South Brent
Devon
TQ10 9JG





Registered number: 14439749 (England and Wales)





Accountants: Nigel Webster & Co
129 North Hill
Plymouth
Devon
PL4 8JY

NW Diagnostics Limited (Registered number: 14439749)

BALANCE SHEET
31 October 2023

Notes £    £   
Fixed assets
Tangible assets 4 212

Current assets
Debtors 5 2,684
Cash at bank 30,458
33,142
Creditors
Amounts falling due within one year 6 7,734
Net current assets 25,408
Total assets less current liabilities 25,620

Capital and reserves
Called up share capital 7 7
Retained earnings 25,613
Shareholders' funds 25,620

NW Diagnostics Limited (Registered number: 14439749)

BALANCE SHEET - continued
31 October 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 October 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 October 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit & Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 February 2024 and were signed on its behalf by:





Mrs J A Foster - Director


NW Diagnostics Limited (Registered number: 14439749)

NOTES TO THE FINANCIAL STATEMENTS
for the period 24 October 2022 to 31 October 2023

1. STATUTORY INFORMATION

NW Diagnostics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration receivable for the rendering of services which is recognised according to the date of the provision of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Equipment - 15% on reducing balance

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Profit & Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

NW Diagnostics Limited (Registered number: 14439749)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the period 24 October 2022 to 31 October 2023

2. ACCOUNTING POLICIES - continued

Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 .

4. TANGIBLE FIXED ASSETS
Equipment
£   
Cost
Additions 250
At 31 October 2023 250
Depreciation
Charge for period 38
At 31 October 2023 38
Net book value
At 31 October 2023 212

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade debtors 2,684

NW Diagnostics Limited (Registered number: 14439749)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the period 24 October 2022 to 31 October 2023

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Taxation and social security 6,750
Other creditors 984
7,734

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
2 Ordinary shares £1 2
1 Ordinary A shares £1 1
1 Ordinary B shares £1 1
1 Ordinary C Shares £1 1
1 Ordinary D Shares £1 1
1 Ordinary E shares £1 1
7

The following shares were issued during the period for cash at par :

2 Ordinary shares shares of £1
1 Ordinary A shares share of £1
1 Ordinary B shares share of £1
1 Ordinary C Shares share of £1
1 Ordinary D Shares share of £1
1 Ordinary E shares share of £1

8. RELATED PARTY DISCLOSURES

At the balance sheet date, the copmany owed £492 to its directors jointly.

9. ULTIMATE CONTROLLING PARTY

The company is ultimately controlled by its directors.